DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. SPY
3. NVDA
4. MU
5. AVAV
6. DLR
7. TSLA
8. EOSE
9. ABVX
10. VSH

Go back to DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results

DiaMedica Therapeutics Inc. (DMAC) Tops Q2 EPS by 2c

August 14, 2023 4:19 PM EDT

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.

... More